Edgar Ben-Josef

faculty photo
Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
Vice-Chair for Translational Research, Department of Radiation Oncology University of Pennsylvania
Interim Director of Clinical Research, Department of Radiation Oncology
Department: Radiation Oncology

Contact information
Department of Radiation Oncology
University of Pennsylvania
Perelman Center for Advanced Medicine
2 West
3400 Civic Center Blvd.
Philadelphia, PA 19104
Office: 215-662-3932
Education:
B.Med.Sc.
The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel, 1980.
M.D.
The Hebrew University-Hadassah School of Medicine, 1983.
Permanent link
 

Description of Itmat Expertise

pancreatic cancer biology; wnt and c-met signaling and invasion/treatment resistance in pancreatic cancer; samll bowel radiation injury

Selected Publications

Sonny Batra, Lauren Comisar, J. Nicholas Lukens, Maura Kirk, Jim Mcdonough, Stephan Both, Edgar Ben-Josef, Jim M. Metz, John P. Plastaras: Lower Rates of Acute Gastrointestinal Toxicity with Pencil Beam Proton Therapy Relative to IMRT in Neo-adjuvant Chemoradiation for Rectal Cancer. 2015 Gastrointestinal Cancers Symposium 2015.

Theodore S. Hong, Jennifer Yon-Li Wo, Beow Y. Yeap, Edgar Ben-Josef, Erin I McDonnell, Lorraine C. Drapek, Lawrence Scott Blaszkowsky, Eunice Lee Kwak, Jeffrey W. Clark, Lipika Goyal, David P. Ryan, Milind M. Javle, John A. Wolfgang, Ronald Arellano, John Thomas Mullen, Cristina Ferrone, Kenneth Tanabe, Thomas F. DeLaney, Christopher H. Crane, Andrew X. Zhu;: Multi-institutional phase II study of high dose, hypofractionated proton beam therapy (HF-PBT) for unresectable primary liver cancers: Long term outcomes in patients (pts) with intrahepatic cholangiocarcinoma (ICC) ASCO Annual Meeting 2015 2015.

Terrance Williams: "Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer" Scientific Reports 2015 Notes: submitted.

Berman AT; Barsky AR; Mick R; Metz JM; Ben-Josef E; Teitelbaum U; Williams N; Kucharczuk JC; Margolis DJ; Plastaras JP: Perioperative Complications after Neoadjuvant Chemoradiation for Locally-Advanced Esophageal Cancer (LAEC): A Comparison of Platinum/5-FU (PF)and Carboplatin/Paclitaxel (PT). ASTRO annual meeting 2014 2014.

Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng FY, Lawrence TS, Ross BD: A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol. 7(5): 644-9, 2014.

Daniel R. Wahl, MD, PhD; Matthew H. Stenmark, MD; Erqi Liu, MD; Yebin Tao, MS; Oliver E. Lee, MS; Matthew J. Schipper, PhD; Elaine M. Caoili, MD, MS; Edgar Ben-Josef, MD; Theodore S. Lawrence, MD, PhD; Mary Feng, MD: SBRT provides equivalent local control compared to RFA for the treatment of hepatocellular carcinoma with minimal toxicity. ASTRO annual meeting 2014 2014.

Thompson RF, Mayekar SU, Zhai H, Both S, Apisarnthanarax S, Metz JM, Plastaras JP, Ben-Josef E : A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys. 41 (8): 081711, 2014.

Yi Sun, Edgar Ben-josef: DEPTOR has growth suppression activity against pancreatic cancer cells Oncotarget 2014.

Annemarie Fernandes, Abigail Berman, Stefan Both,Kristi Varillo, James Metz, Edgar Ben-Josef, John Plastaras: Clinical Outcomes of Proton Beam Reirradiation for Esophageal Cancer. ASTRO annual meeting 2014 2014.

Serrano PE, Herman JM, Griffith KA, Zalupski MM, Kim EJ, Bekaii-Saab TS, Ben-Josef E, Dawson LA, Ringash J, Wei AC: Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma. Int J Radiat Oncol Biol Phys. Page: S0360-3016(14)00704-4 [Epub ahead of print] 2014.

back to top
Last updated: 03/16/2015
The Trustees of the University of Pennsylvania